Achalasia is an uncommon disorder that results from the degeneration of ganglion cells of
the myenteric plexus in the lower esophageal wall. It is manifested by a loss of peristalsis in …

ESGE recommends the use of a graded pneumatic dilation protocol in achalasia, starting
with a 30-mm dilation and followed by a 35-mm dilation at a planned interval of 2–4 weeks …

Achalasia was first described in the 17th century and its treatment continues to be
challenging. Palliative treatment involves disruption of the lower esophageal sphincter …

Results: No intra-operative complications were observed, and no mortalities resulted. During
the 12 to 24-month follow-up period, recurrent dysphagia was observed mostly in the spastic …

Methods A comprehensive electronic database search was executed with the help of an
expert medical librarian. The search was designed to capture AEs associated with …

The discovery of botulinum toxin A (BTX)'s therapeutic properties has led to studies
evaluating its usefulness in multiple medical disorders. Its use in the gastrointestinal (GI) …

Background Relieving esophagogastric junction (EGJ) obstruction has been the focus of
treatment for achalasia cardia. The recovery of peristalsis has been an elusive goal. Studies …

Background: The aim of the study was to share the effectiveness of pneumatic dilation in
geriatric achalasia patients. Methods: Achalasia patients over the age of 65 and those under …

Disorders of esophagogastric junction (EGJ) outflow, including achalasia and EGJ outflow
obstruction, are motility disorders characterized by inadequate relaxation of lower …

Background Although achalasia patients are undernourished, studies are scant. We
studied:(i) the frequency of malnutrition among these patients and (ii) the effect of pneumatic …